Immune-Mediated Necrotizing Myopathy: A Review for Clinicians

키워드

참고문헌 (29)

1. Bohan A, "Polymyositis and dermatomyositis(first of two parts)", N Engl J Med, 292, pp.344~347 (1975)
2. Lundberg IE, "Classification of myositis", Nat Rev Rheumatol, 14, pp.269~278 (2018)
3. Amato AA, "Unicorns, dragons, polymyositis, and other mythological beasts", Neurology, 61, pp.288~289 (2003)
4. Pinal-Fernandez I, "Immune-mediated necrotizing myopathy", Curr Rheumatol Rep, 20, pp.21~ (2018)
5. Allenbach Y, "224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016", Neuromuscul Disord, 28, pp.87~99 (2018)
6. Okada N, "Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle", J Immunol, 138, pp.3219~3223 (1987)
7. Christopher-Stine L, "A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy", Arthritis Rheum, 62, pp.2757~2766 (2010)
8. Mammen AL, "Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy", Arthritis Rheum, 63, pp.713~721 (2011)
9. Meyer A, "Incidence and prevalence of inflammatory myopathies : a systematic review", Rheumatology(Oxford), 54, pp.50~63 (2015)
10. 조수경, "Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study", Journal of Korean Medical Science, 34(8), pp.1~11 (2019), 대한의학회
11. Allenbach Y, "Immune-mediated necrotizing myopathy : clinical features and pathogenesis", Nat Rev Rheumatol, 16, pp.689~701 (2020)
12. Liang WC, "Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies", Rheumatology(Oxford), 56, pp.287~293 (2017)
13. Ge Y, "Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies in Chinese patients with idiopathic inflammatory myopathies", PLoS One, 10, pp.e0141616~ (2015)
14. Suzuki S, "Inflammatory myopathy with anti-signal recognition particle antibodies : case series of 100 patients", Orphanet J Rare Dis, 10, pp.61~ (2015)
15. Watanabe Y, "Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy", J Neurol Neurosurg Psychiatry, 87, pp.1038~1044 (2016)
16. Kurashige T, "Anti-HMGCR myopathy : clinical and histopathological features, and prognosis", Curr Opin Rheumatol, 33, pp.554~562 (2021)
17. Pinal-Fernandez I, "Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle", Arthritis Care Res(Hoboken), 69, pp.263~270 (2017)
18. Yang H, "Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort", BMC Musculoskelet Disord, 23, pp.425~ (2022)
19. Allenbach Y, "High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody", Brain, 139(Pt 8), pp.2131~2135 (2016)
20. Tiniakou E, "More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy", Rheumatology(Oxford), 56, pp.787~794 (2017)
21. Mammen AL, "Statin-associated autoimmune myopathy", N Engl J Med, 374, pp.664~669 (2016)
22. Landon-Cardinal O, "Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI", Semin Arthritis Rheum, 50, pp.1437~1440 (2020)
23. Pinal-Fernandez I, "Thigh muscle MRI in immune-mediated necrotising myopathy : extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity", Ann Rheum Dis, 76, pp.681~687 (2017)
24. Benveniste O, "Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy", Arthritis Rheum, 63, pp.1961~1971 (2011)
25. Arouche-Delaperche L, "Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies : myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies", Ann Neurol, 81, pp.538~548 (2017)
26. Bergua C, "In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy", Ann Rheum Dis, 78, pp.131~139 (2019)
27. Rademacher JG, "Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy : comparative analysis of a single-centre cohort and published data", Clin Exp Rheumatol, 40, pp.320~328 (2022)
28. Landon-Cardinal O, "Rituximab in the treatment of refractory anti-HMGCR immune-mediated necrotizing myopathy", J Rheumatol, 46, pp.623~627 (2019)
29. Binns EL, "Effective induction therapy for anti-SRP associated myositis in childhood : a small case series and review of the literature", Pediatr Rheumatol Online J, 15, pp.77~ (2017)

관련 논문AI추천